Incidence of SARS-CoV-2 in people with cystic fibrosis in Europe between February and June 2020.

Last updated on 31-5-2021 by Géraldine Daneau

Public Access


Peer reviewed scientific article


Article written during project(s) : 


BACKGROUND: Viral infections can cause significant morbidity in cystic fibrosis (CF). The current Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) pandemic could therefore have a serious impact on the health of people with CF (pwCF). METHODS: We used the 38-country European Cystic Fibrosis Society Patient Registry (ECFSPR) to collect case data about pwCF and SARS-CoV-2 infection. RESULTS: Up to 30 June 2020, 16 countries reported 130 SARS-CoV-2 cases in people with CF, yielding an incidence of 2.70/1000 pwCF. Incidence was higher in lung-transplanted patients (n=23) versus…

Associated health topics:

QR code

QR code for this page URL